Publications

The scientists at the Fiona Elsey Cancer Research Institute aim to publish research papers that will build an international reputation for the highest quality cancer research in selected fields.

Research Publications

Professor George Kannourakis MB, BS, B(Med)Sc, PhD, FRACP Honorary Research Director, Fiona Elsey Cancer Research Institute

Knockdown of stem cell regulator Oct4A in ovarian cancer reveals cellular reprogramming associated with key regulators of cytoskeleton-extracellular matrix remodeling.
Samardzija C, Greening D, Escalona RM, Chen M, Bilandzic  M, Luwor R, Kannourakis G, Findlay JK and Ahmed N
Journal: Scientific Reports
Date Published: April 13 2017

 

Early treatment intensification with R-ICE and 90Y-ibritumomab tiuxetan (Zevalin)-BEAM stem cell transplantation in patients with high-risk diffuse large B-cell lymphoma and positive interim PET after 4 cycles of R-CHOP-14
Hertzberg M, Gandhi MK, Trotman J, Butcher B, Taper J, Johnston A, Gill D, Ho SJ, Cull G, Fay K, Chong G, Grigg A, Lewis ID, Milliken S, Renwick W, Hahn U, Filshie R, Kannourakis G, Watson AM, Warburton P, Wirth A, Seymour JF, Hofman MS, Hicks RJ
JournalHaematologica
Date Published: November 2016

 

Pembrolizumab versus Chemotherapy for PD-L1-Positive Non-Small-Cell Lung Cancer
Reck M, Rodríguez-Abreu D, Robinson AG, Hui R, Csőszi T, Fülöp A, Gottfried M, Peled N, Tafreshi A, Cuffe S, O'Brien M, Rao S, Hotta K, Leiby MA, Lubiniecki GM, Shentu Y, Rangwala R, Brahmer
JournalN Engl J Med
Date PublishedOctober 2016

 

Unique proteome signature of post-chemotherapy ovarian cancer ascites-derived tumor cells.
Ahmed N, Greening D, Samardzija C, Escalona RM, Chen M, Findlay JK, Kannourakis G
JournalSci Rep
Date Published: July 2016

 

 

Coalition of Oct4A and β1 integrins in facilitating metastasis in ovarian cancer
Samardzija C, Luwor RB, Quinn MA, Kannourakis G, Findlay JK, Ahmed N
JournalBMC cancer
Date Published: July 2016

 

Evaluation of response from axitinib per Response Evaluation Criteria in Solid Tumors versus Choi criteria in previously treated patients with metastatic renal cell carcinoma.
Karakiewicz PI, Nott L, Joshi A, Kannourakis G, Tarazi J, Alam M
JournalOnco Targets Ther
Date Published: May 2016

 

Observation versus late reintroduction of letrozole as adjuvant endocrine therapy for hormone receptor-positive breast cancer (ANZ0501 LATER): an open-label randomised, controlled trial.
Zdenkowski N, Forbes JF, Boyle FM, Kannourakis G, Gill PG, Bayliss E, Saunders C, Della-Fiorentina S, Kling N, Campbell I, Mann GB, Coates AS, Gebski V, Davies L, Thornton R, Reaby L, Cuzick J, Green M; Australia and New Zealand Breast Cancer Trials Group
JournalAnn Oncol
Date Published: Feb 2016

 

Resolution of norfloxacin-induced acute liver failure after N-acetylcysteine therapy: further support for the use of NAC in drug-induced ALF?
Elliott TR, Symes T, Kannourakis G, Angus P
JournalBMJ Case Rep
Date Published: Jan 2016

 

Anastrozole versus tamoxifen for the prevention of locoregional and contralateral breast cancer in postmenopausal women with locally excised ductal carcinoma in situ (IBIS-II DCIS): a double-blind, randomised controlled trial.
Forbes JF, Sestak I, Howell A, Bonanni B, Bundred N, Levy C, von Minckwitz G, Eiermann W, Neven P, Stierer M, Holcombe C, Coleman RE, Jones L, Ellis I, Cuzick J;
JournalLancet
Date Published

 

Suppression subtractive hybridization method for the identification of a new strain of murine hepatitis virus from xenografted SCID mice.
Islam MM, Toohey B, Purcell DF, Kannourakis G
JournalArch Virol
Date Published: Sep 2015

 

An emerging role for immune regulatory subsets in chronic lymphocytic leukaemia.
Wallace ME, Alcantara MB, Minoda Y, Kannourakis G, Berzins SP
JournalInt Immunopharmacol
Date Published: Apr 2015

 

EVERSUN: a phase 2 trial of alternating sunitinib and everolimus as first-line therapy for advanced renal cell carcinoma
Davis ID, Long A, Yip S, Espinoza D, Thompson JF, Kichenadasse G, Harrison M, Lowenthal RM, Pavlakis N, Azad A, Kannourakis G, Steer C, Goldstein D, Shapiro J, Harvie R, Jovanovic L, Hudson AL, Nelson CC, Stockler MR, Martin A
JournalAnn Oncol
Date Published: Feb 2015

 

Adjuvant ovarian suppression in premenopausal breast cancer
Francis PA, Regan MM, Fleming GF, Láng I, Ciruelos E, Bellet M, Bonnefoi HR, Climent MA, Da Prada GA, Burstein HJ, Martino S, Davidson NE, Geyer CE Jr, Walley BA, Coleman R, Kerbrat P, Buchholz S, Ingle JN, Winer EP, Rabaglio-Poretti M, Maibach R, Ruepp B, Giobbie-Hurder A, Price KN, Colleoni M, Viale G, Coates AS, Goldhirsch A, Gelber RD; SOFT Investigators.; International Breast Cancer Study Group
JournalN Engl J Med
Date Published: Jan 2015

 

Polyclonal T-cells express CD1a in Langerhans cell histiocytosis (LCH) lesions
West JA, Olsen SL, Mitchell JM, Priddle RE, Luke JM, Akefeldt SO, Henter JI, Turville C, Kannourakis G
JournalPLoS One
Date Published: Oct 2014

 

Adjuvant exemestane with ovarian suppression in premenopausal breast cancer
Pagani O, Regan MM, Walley BA, Fleming GF, Colleoni M, Láng I, Gomez HL, Tondini C, Burstein HJ, Perez EA, Ciruelos E, Stearns V, Bonnefoi HR, Martino S, Geyer CE Jr, Pinotti G, Puglisi F, Crivellari D, Ruhstaller T, Winer EP, Rabaglio-Poretti M, Maibach R, Ruepp B, Giobbie-Hurder A, Price KN, Bernhard J, Luo W, Ribi K, Viale G, Coates AS, Gelber RD, Goldhirsch A, Francis PA; TEXT and SOFT Investigators.; International Breast Cancer Study Group
JournalN Engl J Med
Date Published: Jul 2014

 

Axitinib versus sorafenib in advanced renal cell carcinoma: subanalyses by prior therapy from a randomised phase III trial
Escudier B, Michaelson MD, Motzer RJ, Hutson TE, Clark JI, Lim HY, Porfiri E, Zalewski P, Kannourakis G, Staehler M, Tarazi J, Rosbrook B, Cisar L, Hariharan S, Kim S, Rini BI
JournalBr J Cancer
Date Published: May 2014

 

Acute exercise leads to regulation of telomere-associated genes and microRNA expression in immune cells
Chilton WL, Marques FZ, West J, Kannourakis G, Berzins SP, O'Brien BJ, Charchar FJ
JournalPLoS One
Date Published: Apr 2014

 

Neoadjuvant chemotherapy with sequential anthracycline-docetaxel with gemcitabine for large operable or locally advanced breast cancer: ANZ 0502 (NeoGem)
McCarthy N, Boyle F, Zdenkowski N, Bull J, Leong E, Simpson A, Kannourakis G, Francis PA, Chirgwin J, Abdi E, Gebski V, Veillard AS, Zannino D, Wilcken N, Reaby L, Lindsay DF, Badger HD, Forbes JF; Australia and New Zealand Breast Cancer Trials Group
JournalBreast
Date Published: Apr 2014

 

Long-term effects of continuing adjuvant tamoxifen to 10 years versus stopping at 5 years after diagnosis of oestrogen receptor-positive breast cancer: ATLAS, a randomised trial
Davies C, Pan H, Godwin J, Gray R, Arriagada R, Raina V, Abraham M, Medeiros Alencar VH, Badran A, Bonfill X, Bradbury J, Clarke M, Collins R, Davis SR, Delmestri A, Forbes JF, Haddad P, Hou MF, Inbar M, Khaled H, Kielanowska J, Kwan WH, Mathew BS, Mittra I, Müller B, Nicolucci A, Peralta O, Pernas F, Petruzelka L, Pienkowski T, Radhika R, Rajan B, Rubach MT, Tort S, Urrútia G, Valentini M, Wang Y, Peto R; Adjuvant Tamoxifen: Longer Against Shorter (ATLAS) Collaborative Group
JournalLancet
Date Published: Mar 2013

 

Breast-cancer adjuvant therapy with zoledronic acid.
Coleman RE, Marshall H, Cameron D, Dodwell D, Burkinshaw R, Keane M, Gil M, Houston SJ, Grieve RJ, Barrett-Lee PJ, Ritchie D, Pugh J, Gaunt C, Rea U, Peterson J, Davies C, Hiley V, Gregory W, Bell R; AZURE Investigators..
JournalN Engl J Med
Date Published: Oct 2011

 

Adjuvant trastuzumab in HER2-positive breast cancer
Slamon D, Eiermann W, Robert N, Pienkowski T, Martin M, Press M, Mackey J, Glaspy J, Chan A, Pawlicki M, Pinter T, Valero V, Liu MC, Sauter G, von Minckwitz G, Visco F, Bee V, Buyse M, Bendahmane B, Tabah-Fisch I, Lindsay MA, Riva A, Crown J; Breast Cancer International Research Group
JournalN Engl J Med
Date Published: Oct 2011

 

A cryptic deletion in 5q31.2 provides further evidence for a minimally deleted region in myelodysplastic syndromes.
MacKinnon RN, Kannourakis G, Wall M, Campbell LJ
JournalCancer Genet
Date Published: Apr 2011

 

The Severe Chronic Neutropenia International Registry: 10-Year Follow-up Report
Dale DC, Bolyard AA, Schwinzer BG, Pracht G, Bonilla MA, Boxer L, Freedman MH, Donadieu J, Kannourakis G, Alter BP, Cham BP, Winkelstein J, Kinsey SE, Zeidler C, Welte K
JournalSupport Cancer Ther
Date Published: Jun 2005

 

Neutrophil elastase mutations and risk of leukaemia in severe congenital neutropenia
Rosenberg PS, Alter BP, Link DC, Stein S, Rodger E, Bolyard AA, Aprikyan AA, Bonilla MA, Dror Y, Kannourakis G, Newburger PE, Boxer LA, Dale DC
JournalBr J Haematol
Date Published: Nov 2007

 

Three cases of activation of cutaneous squamous-cell carcinoma during treatment with prolonged administration of rituximab
Fogarty GB, Bayne M, Bedford P, Bond R, Kannourakis G
JournalClin Oncol
Date Published: Jun 2005

 

The incidence of leukemia and mortality from sepsis in patients with severe congenital neutropenia receiving long-term G-CSF therapy.
Rosenberg PS, Alter BP, Bolyard AA, Bonilla MA, Boxer LA, Cham B, Fier C, Freedman M, Kannourakis G, Kinsey S, Schwinzer B, Zeidler C, Welte K, Dale DC; Severe Chronic Neutropenia International Registry
JournalBlood
Date Published: Feb 2006

 

Severe chronic neutropenia: treatment and follow-up of patients in the Severe Chronic Neutropenia International Registry.
Dale DC, Cottle TE, Fier CJ, Bolyard AA, Bonilla MA, Boxer LA, Cham B, Freedman MH, Kannourakis G, Kinsey SE, Davis R, Scarlata D, Schwinzer B, Zeidler C, Welte K
JournalAm J Hematol
Date Published: 2003

 

A time to kill: viral manipulation of the cell death program.
Hay S, Kannourakis G
JournalJ Gen Virol
Date Published:

 

Glycogen storage disease.
Kannourakis G
JournalSemin Hematol
Date Published: Apr 2002

 

Mutations in the gene encoding neutrophil elastase in congenital and cyclic neutropenia.
Dale DC, Person RE, Bolyard AA, Aprikyan AG, Bos C, Bonilla MA, Boxer LA, Kannourakis G, Zeidler C, Welte K, Benson KF, Horwitz M
JournalBlood
Date Published: Oct 2000

 

Myelodysplasia syndrome and acute myeloid leukemia in patients with congenital neutropenia receiving G-CSF therapy.
Freedman MH, Bonilla MA, Fier C, Bolyard AA, Scarlata D, Boxer LA, Brown S, Cham B, Kannourakis G, Kinsey SE, Mori PG, Cottle T, Welte K, Dale DC.
JournalBlood
Date Published: Jul 2000

 

Novel endogenous type D retroviral particles expressed at high levels in a SCID mouse thymic lymphoma.
Ristevski S, Purcell DF, Marshall J, Campagna D, Nouri S, Fenton SP, McPhee DA, Kannourakis G
JournalJ Virol
Date Published: Jun 99

 

Perivascular T cells express the pro-inflammatory chemokine RANTES mRNA in multiple sclerosis lesions
Hvas J, McLean C, Justesen J, Kannourakis G, Steinman L, Oksenberg JR, Bernard CC
JournalScand J Immunol
Date Published: Mar 97

 

Leukemia inhibitory factor and interleukin-6 are produced by diseased and regenerating skeletal muscle
Kurek JB, Nouri S, Kannourakis G, Murphy M, Austin L
JournalMuscle Nerve
Date Published: Oct 96

 

EWS/FLI-1 fusion transcript detection and MIC2 immunohistochemical staining in the diagnosis of Ewing's sarcoma.
Lee CS, Southey MC, Waters K, Kannourakis G, Georgiou T, Armes JE, Chow CW, Venter DJ
JournalPediatr Pathol Lab Med
Date Published: May 96

 

Cytogenetic and DNA analysis of two neuroectodermal tumors without a simple t(11;22)
Slater HR, Tiong T, Konstantakopoulos S, Sham C, Petrovic V, Voullaire L, Kannourakis G​
JournalCancer Genet Cytogenet
Date Published: Aug 95

 

Soluble antigen can cause enhanced apoptosis of germinal-centre B cells.
Pulendran B, Kannourakis G, Nouri S, Smith KG, Nossal GJ
JournalNature
Date Published: May 95

 

bcl-2 transgene expression can protect neurons against developmental and induced cell death.
Farlie PG, Dringen R, Rees SM, Kannourakis G, Bernard O
JournalProc Natl Acad Sci U S A
Date Published: May 95

 

Viable bone marrow stromal cells are required for the in vitro survival of B-cell precursor acute lymphoblastic leukemic cells.
Ashley DM, Bol SJ, Kannourakis G
JournalLeukemia Research
Date Published: Feb 95

 

Flow cytometric analysis of intercellular adhesion between B-cell precursor acute lymphoblastic leukemic cells and bone marrow stromal cells
Ashley DM, Bol SJ, Tucker DP, Waugh CM, Kannourakis G
JournalLeukemia
Date Published: Jan 95

 

Kiz-1, a protein with LIM zinc finger and kinase domains, is expressed mainly in neurons
Bernard O, Ganiatsas S, Kannourakis G, Dringen R
JournalCell Growth Differ
Date Published: Nov 94

 

The role of cytokines in the pathogenesis of Langerhans cell histiocytosis
Kannourakis G, Abbas A
JournalBr J Cancer Suppl
Date Published: Sep 94

 

The biology of erythropoietin and its role in the anaemia of prematurity
Kannourakis G
JournalJ Paediatr Child Health
Date Published: Aug 94

 

Human bone marrow stromal cell contact and soluble factors have different effects on the survival and proliferation of paediatric B-lineage acute lymphoblastic leukaemic blasts
Ashley DM, Bol SJ, Kannourakis G.
JournalLeuk Res
Date Published: May 94

 

Dose-intensive cyclophosphamide with etoposide and vincristine for pediatric solid tumors: a phase I/II pilot study by the Australia and New Zealand Childhood Cancer Study Group
White L, McCowage G, Kannourakis G, Nayanar V, Colnan L, Kellie S, Shaw P, Seshadri R, Lockwood L, Tiedemann K, et al.
JournalJ Clin Oncol
Date Published: Mar 94

 

Measurement of the growth parameters of precursor B-acute lymphoblastic leukaemic cells in co-culture with bone marrow stromal cells; detection of two cd10 positive populations with different proliferative capacities and survival
Ashley DM, Bol SJ, Kannourakis G
JournalLeuk Res
Date Published: Jan 94

 

A novel approach to the measurement of different in vitro leukaemic cell growth parameters: the use of PKH GL fluorescent probes
Ashley DM, Bol SJ, Waugh C, Kannourakis G
JournalLeuk Res
Date Published: Oct 93

 

Characterization of stroma-adherent colony-forming cells: a clonogenic assay for early hemopoietic cells?
Tucker D, Bol S, Kannourakis G
JournalExp Hematol
Date Published: Mar 93

 

SCL gene in human tumors
Rockman S, Begley CG, Kannourakis G, Mann GJ, Dobrovic AN, Kefford RF, McGrath K
JournalLeukemia
Date Published: Jul 92

 

Proliferative properties of unfractionated, purified, and single cell human progenitor populations stimulated by recombinant human interleukin-3
Kannourakis G, Johnson GR
JournalBlood
Date Published: Jan 90

 

Effects of recombinant human granulocyte colony-stimulating factor on hematopoietic progenitor cells in cancer patients
Dührsen U, Villeval JL, Boyd J, Kannourakis G, Morstyn G, Metcalf D
JournalBlood
Date Published: Dec 88

 

Enhancement of in vitro beta-thalassemic and normal hematopoiesis by a noncytotoxic monoclonal antibody, 9.1C3: evidence for negative regulation of hematopoiesis by monocytes and natural killer cells
Kannourakis G, Johnson GR, Begley CG, Werkmeister JA, Burns GF
JournalBlood
Date Published: Oct 88

 

Pharmacokinetics of human granulocyte-macrophage colony-stimulating factor using a sensitive immunoassay
Cebon J, Dempsey P, Fox R, Kannourakis G, Bonnem E, Burgess AW, Morstyn G
JournalBlood
Date Published: Nov 88

 

Clinical studies with granulocyte colony stimulating factor (G-CSF) in patients receiving cytotoxic chemotherapy
Morstyn G, Campbell L, Dührsen U, Souza LM, Alton NK, Villeval JL, Nicola NA, Boyd AW, Kannourakis G, Cebon J, et al
JournalBehring Inst Mitt
Date Published: Aug 88

 

Activated killer cell lymphoma: an erythrophagocytic syndrome simulating histiocytic medullary histiocytosis
Boyd AW, Ellis DW, Kannourakis G, Begley CG, Mackay IR, Burns GF
JournalPathology
Date Published: Jul 88

 

Clonal proliferation in vitro of individual murine and human hemopoietic cells after fluorescence-activated cell sorting
Kannourakis G, Johnson GR, Battye F
JournalExp Hematol
Date Published: Jun 88

 

Evidence for interactions between monocytes and natural killer cells in the regulation of in vitro hemopoiesis
Kannourakis G, Begley CG, Johnson GR, Werkmeister JA, Burns GF
JournalJ Immunol
Date Published: Apr 88

 

Fractionation of subsets of BFU-E from normal human bone marrow: responsiveness to erythropoietin, human placental-conditioned medium, or granulocyte-macrophage colony-stimulating factor.
Kannourakis G, Johnson GR​
JournalBlood
Date Published: Mar 88

 

A human complement-fixing monoclonal anti-human lymphocyte antibody of rat origin
Georgiou G, Roberton D, Pereira A, Scaletti B, Kannourakis G, Hosking C, Fowler K
JournalImmunol Cell Biol
Date Published: Jun 05

 

Fractionation of normal and beta-thalassemic human hemopoietic progenitor cells by immunomagnetic beads
Kannourakis G, Bol S
JournalExp Hematol
Date Published: 1987

 

Transgenic mice expressing a hemopoietic growth factor gene (GM-CSF) develop accumulations of macrophages, blindness, and a fatal syndrome of tissue damage
Lang RA, Metcalf D, Cuthbertson RA, Lyons I, Stanley E, Kelso A, Kannourakis G, Williamson DJ, Klintworth GK, Gonda TJ, et al
JournalCell
Date Published: Nov 87

 

Studies by radioiodination of normal adult, fetal and leukemic cell membranes
Kannourakis G, Cauchi MN
JournalExp Hematol
Date Published: Sep 87

 

Osmotic fragility of leukaemic and normal lymphocytes
Kannourakis G, Cauchi MN
JournalPathology
Date Published: Apr 78

 

 

Prof Stuart Berzins (BSc(Hons) PhD GCUT)

A three-stage intrathymic development pathway for the mucosal-associated invariant T cell lineage
Koay HF, Gherardin NA, Enders A…Berzins SP
JournalNat Immunol
Date Published: September 2016

 

An emerging role for immune regulatory subsets in chronic lymphocytic leukaemia
Wallace ME, Alcantara MB, Minoda Y, Kannourakis G, Berzins SP
Jounal: Int Immunopharmacol​
Date: Apr 2015

 

Natural killer T cells: drivers or passengers in preventing human disease?
Berzins SP, Ritchie DS
Jounal: Nat Review Immunol
Date: Sep 2014

 

The glucocorticoid receptor 1A3 promoter correlates with high sensitivity to glucocorticoid-induced apoptosis in human lymphocytes.
Liddicoat DR, Kyparissoudis K, Berzins SP, Cole TJ, Godfrey DI.
Jounal: Immunol Cell Biol
Date: Jul 2014

 

Acute exercise leads to regulation of telomere-associated genes and microRNA expression in immune cells.
Chilton WL, Marques FZ, West J, Kannourakis G, Berzins SP, O'Brien BJ, Charchar FJ
Jounal: PLoS One
Date: Apr 2014

 

Natural killer T cell defects in multiple myeloma and the impact of lenalidomide therapy.
Chan AC, Neeson P, Leeansyah E, Tainton K, Quach H, Prince HM, Harrison SJ, Godfrey DI, Ritchie D, Berzins SP
Jounal: Clin Exp Immunol
Date: Jan 2014

 

Ex-vivo analysis of human natural killer T cells demonstrates heterogeneity between tissues and within established CD4(+) and CD4(-) subsets
Chan AC, Leeansyah E, Cochrane A, d'Udekem d'Acoz Y, Mittag D, Harrison LC, Godfrey DI, Berzins SP
Jounal: Clin Exp Immunol
Date: Apr 2013

 

The BH3-only proteins Bim and Puma cooperate to impose deletional tolerance of organ-specific antigens
Gray DH, Kupresanin F, Berzins SP, Herold MJ, O'Reilly LA, Bouillet P, Strasser A
Jounal: Immunity
Date: Sep 2012

 

The NF-κB1 transcription factor prevents the intrathymic development of CD8 T cells with memory properties.
Gugasyan R, Horat E, Kinkel SA, Ross F, Grigoriadis G, Gray D, O'Keeffe M, Berzins SP, Belz GT, Grumont RJ, Banerjee A, Strasser A, Godfrey DI, Tsichlis PN, Gerondakis S.
Jounal: EMBO J
Date: Nov 11

 

Presumed guilty: natural killer T cell defects and human disease.
Berzins SP, Smyth MJ, Baxter AG
Jounal: Nt Rev Immunol
Date: Feb 2011

 

Lessons learned from an unusual presentation of CD3+, CD56- T-cell large granular lymphocyte leukemia
Lee RJ, Ritz N, Chan AC, Berzins SP, Came N, Curtis N, Lim A, Harrison SJ.
Jounal:  J Clin Oncol
Date: Oct  2010

 

Transcriptional regulation of lymphocyte development. Developing NKT cells need their (E) protein
Chan AC, Berzins SP, Godfrey DI
Jounal: Immunol Cell Biol
Date: May 2010

 

Testing the NKT cell hypothesis in lenalidomide-treated myelodysplastic syndrome patients
Chan AC, Neeson P, Leeansyah E, Tainton K, Quach H, Prince HM, Godfrey DI, Ritchie D, Berzins SP
Jounal: Leukemia
Date: Jan 2010

 

An NZW-derived interval on chromosome 7 moderates sialadenitis, but not insulitis in congenic nonobese diabetic mice.
Burt RA, Watkins L, Tan IK, Wang N, Quirk F, Mackin L, Morgan P, Zhang JG, Berzins SP, Morahan G, Brodnicki TC
Jounal: J  Immunol
Date: Jan 2010

 

Immune characterization of an individual with an exceptionally high natural killer T cell frequency and her immediate family
Chan AC, Serwecinska L, Cochrane A, Harrison LC, Godfrey DI, Berzins SP.
Jounal: Clin Exp Immunol
Date: May 2009

 

NKT cell development in the absence of the autoimmune regulator gene (Aire).
Pitt LA, Hubert FX, Scott HS, Godfrey DI, Berzins SP
Jounal: Eur J Immunol
Date: Sep 2008

 

Diverse cytokine production by NKT cell subsets and identification of an IL-17-producing CD4-NK1.1- NKT cell population.
Coquet JM, Chakravarti S, Kyparissoudis K, McNab FW, Pitt LA, McKenzie BS, Berzins SP, Smyth MJ, Godfrey DI
Jounal: Proc Natl Acad Sci U S A
Date: Aug 2008

 

Peripheral NK1.1 NKT cells are mature and functionally distinct from their thymic counterparts
McNab FW, Pellicci DG, Field K, Besra G, Smyth MJ, Godfrey DI, Berzins SP
Jounal: J Immunol
Date: Nov 2007

 

Control points in NKT-cell development.
Godfrey DI, Berzins SP
Jounal: Nat Review Immunol
Date: Aug 2007

 

IL-21 is produced by NKT cells and modulates NKT cell activation and cytokine production
Coquet JM, Kyparissoudis K, Pellicci DG, Besra G, Berzins SP, Smyth MJ, Godfrey DI
Jounal: J Immunol
Date: Mar 2007

 

NKT cells join the war on Lyme disease.
Godfrey DI, Berzins SP
Jounal: Nat Immunol
Date: Oct 2006

 

Retraction: Antigen-induced tolerance by intrathymic modulation of self-recognizing inhibitory receptors.
Hayakawa Y, Berzins SP, Crowe NY, Godfrey DI, Smyth MJ.
Jounal: 
Date: 

 

Antigen challenge inhibits thymic emigration.
Uldrich AP, Berzins SP, Malin MA, Bouillet P, Strasser A, Smyth MJ, Boyd RL, Godfrey DI
Jounal: J Immunol
Date: Apr 2006

 

Long-term retention of mature NK1.1+ NKT cells in the thymus
Berzins SP, McNab FW, Jones CM, Smyth MJ, Godfrey DI
Jounal: J Immunol
Date: Apr 2006

 

Localization of Idd11 is not associated with thymus and nkt cell abnormalities in NOD mice
Brodnicki TC, Fletcher AL, Pellicci DG, Berzins SP, McClive P, Quirk F, Webster KE, Scott HS, Boyd RL, Godfrey DI, Morahan G
Jounal: Diabetes
Date: Dec 2005

 

Differential antitumor immunity mediated by NKT cell subsets in vivo
Crowe NY, Coquet JM, Berzins SP, Kyparissoudis K, Keating R, Pellicci DG, Hayakawa Y, Godfrey DI, Smyth MJ
Jounal: J Exp Med
Date: Nov 2005

 

The influence of CD1d in postselection NKT cell maturation and homeostasis
McNab FW, Berzins SP, Pellicci DG, Kyparissoudis K, Field K, Smyth MJ, Godfrey DI.
Jounal: J Immunol
Date: Sep 2005

 

The cellular mechanism of Aire control of T cell tolerance
Anderson MS, Venanzi ES, Chen Z, Berzins SP, Benoist C, Mathis D
Jounal: Immunity
Date: Aug 2005

 

Activation of thymic regeneration in mice and humans following androgen blockade.
Sutherland JS, Goldberg GL, Hammett MV, Uldrich AP, Berzins SP, Heng TS, Blazar BR, Millar JL, Malin MA, Chidgey AP, Boyd RL.
Jounal: J Immunol
Date: Aug 2005

 

Working with NKT cells--pitfalls and practicalities
Berzins SP, Smyth MJ, Godfrey DI
Jounal: Curr Opin Immunol
Date: Jun 2005

 

Limited correlation between human thymus and blood NKT cell content revealed by an ontogeny study of paired tissue samples
Berzins SP, Cochrane AD, Pellicci DG, Smyth MJ, Godfrey DI.
Jounal: Eur J Immunol
Date: Apr 2005

 

Are we really on the right TRAIL?
Cretney E, Uldrich AP, Berzins SP, Strasser A, Godfrey DI, Smyth MJ
Jounal: Immunol Res
Date Published: Jun 2005

 

Parallels and distinctions between T and NKT cell development in the thymus
Berzins SP, Uldrich AP, Pellicci DG, McNab F, Hayakawa Y, Smyth MJ, Godfrey DI
Jounal: Immunol Cell Biol
Date: Jun 2004

 

Systemic NKT cell deficiency in NOD mice is not detected in peripheral blood: implications for human studies.
Berzins SP, Kyparissoudis K, Pellicci DG, Hammond KJ, Sidobre S, Baxter A, Smyth MJ, Kronenberg M, Godfrey DI
Jounal: Immunol Cell Biol
Date: Jun 2014

 

Antigen-induced tolerance by intrathymic modulation of self-recognizing inhibitory receptors
Hayakawa Y, Berzins SP, Crowe NY, Godfrey DI, Smyth MJ.
Jounal: RETRACTION
Date: 

 

Normal thymocyte negative selection in TRAIL-deficient mice
Cretney E, Uldrich AP, Berzins SP, Strasser A, Godfrey DI, Smyth MJ
Jounal: J Exp Med
Date: Aug 2003

 

T-cell compartments of prediabetic NOD mice
Berzins SP, Venanzi ES, Benoist C, Mathis D
Jounal: Diabetes
Date Published: Feb 2003

 

Thymic regeneration: teaching an old immune system new tricks
Berzins SP, Uldrich AP, Sutherland JS, Gill J, Miller JF, Godfrey DI, Boyd RL
Jounal: Trends Mol Med
Date: 

 

Projection of an immunological self shadow within the thymus by the aire protein
Anderson MS, Venanzi ES, Klein L, Chen Z, Berzins SP, Turley SJ, von Boehmer H, Bronson R, Dierich A, Benoist C, Mathis D
Jounal: Science
Date: Oct 2002

 

Essential role for the lymphostromal plasma membrane Ly-6 superfamily molecule thymic shared antigen 1 in development of the embryonic adrenal gland
Zammit DJ, Berzins SP, Gill JW, Randle-Barrett ES, Barnett L, Koentgen F, Lambert GW, Harvey RP, Boyd RL, Classon BJ
Jounal: Mol Cell Biol
Date: Nov 2002

 

A central role for thymic emigrants in peripheral T cell homeostasis
Berzins SP, Godfrey DI, Miller JF, Boyd RL
Jounal: Proc Natl Acad Sci U S A
Date: Aug 1999

 

Thymic shared antigen-2: a novel cell surface marker associated with T cell differentiation and activation.
Berzins SP, Davey GM, Randle-Barrett ES, Malin MA, Classon BJ, Fraser S, Boyd RL
Jounal: J Immunol
Date: May 1999

 

The role of the thymus and recent thymic migrants in the maintenance of the adult peripheral lymphocyte pool.
Berzins SP, Boyd RL, Miller JF
Jounal: J Exp Med
Date: Jun 1998

 

Expression of the gastric H/K-ATPase alpha-subunit in the thymus may explain the dominant role of the beta-subunit in the pathogenesis of autoimmune gastritis
Alderuccio F, Gleeson PA, Berzins SP, Martin M, Van Driel IR, Toh BH
Jounal: Autoimmunity
Date: Jun 2005

 

 

Professor Nuzhat Ahmed, BSc Hons (DU), MSc (KUL), PhD (ANU)

 

Surface Profiling of Extracellular Vesicles from Plasma or Ascites Fluid Using DotScan Antibody Microarrays- Chapter 20.

Larissa Belov, Susannah Hallal, Kieran Matic, Jerry Zhou, Sandra Wissmueller, Nuzhat Ahmed, Sumaiya Tanjil, Stephen P. Mulligan, O. Giles Best, Richard J. Simpson, and Richard I. Christopherson

Journal: Methods Molecular Biology, Vol. 1619, Serum/Plasma Proteomics, 978-1-4939-7056-8
Date Published: 2017

 

Knockdown of stem cell regulator Oct4A in ovarian cancer reveals cellular reprogramming associated with key regulators of cytoskeleton-extracellular matrix remodeling.

Samardzija C, Greening D, Escalona RM, Chen M, Bilandzic  M, Luwor R, Kannourakis G, Findlay JK and Ahmed N
Journal: Scientific Reports
Date Published: April 13 2017

 

Coalition of Oct4A and β1 integrins in facilitating metastasis in ovarian cancer
Samardzija C, Luwor RB, Quinn MA, Kannourakis G, Findlay JK and Ahmed N
Journal: BMC Cancer

Date: Jul-16

 

Unique proteome signature of post-chemotherapy ovarian cancer ascites-derived tumor cells
Ahmed N, Greening D, Samardzija C, Escalona RM, Chen M,  Findlay JK and Kannourakis G 
Journal: Scientific Reports 
Date: July 2016

 

A critical role of Oct4A in mediating metastasis and disease-free survival in a mouse model of ovarian cancer
Samardzija C, Luwor R, Volchek M, Quinn M, Findlay J and Ahmed N
Journal: Molecular Cancer
Date: August 2015

 

Enhanced activation of STAT3 in ascites-derived recurrent ovarian tumors: inhibition of cisplatin-induced STAT3 activation reduced tumorigenicity of ovarian cancer by a loss of cancer stem cell-like characteristics
Abubaker K, Latifi A, Chan E, Luwor RB, Burns CJ, Thompson EW, Findlay JK and Ahmed N
Journal: Journal of Cancer Stem Cell Research
Date: January 2015

 

Distinct molecular signature of recurrent ovarian tumor cells isolated from the ascites of advanced-stage serous ovarian cancer patients
Latifi A, Escalona R, Quinn MA, Thompson EW, Findlay JK and Ahmed N
Journal: Journal of Cancer Stem Cell Research
Date: October 2014

 

Betaglycan blocks metastatic behaviors in human granulosa cell tumors by suppressing NFkB-mediated induction of MMP2
Bilandzic M, Wang Y, Ahmed N, Luwor RB, Zhu HJ, H. TaFindlay JK, and Stenvers KL
Journal: Cancer Letters
Date: Nov 2014

Targeted disruption of JAK2/STAT3 pathway in combination with systemic administration of paclitaxel inhibits the priming of ovarian cancer stem cells leading to a reduced tumor burden
Abubaker K, Luwor RB, Escalona R, McNally O, Quinn MA, Thompson EW, Findlay JK Ahmed N 
Journal: Frontiers in Oncology
Date: May 2014
 

 

Inhibition of the JAK2/STAT3 pathway in ovarian cancer results in the loss of cancer stem cell-like characteristics and a reduced tumor burden
Abubaker K, Luwor RB, Hongjian Z, Orla M, Quinn MA, Burns JC, Thompson EW, Findlay JK, Ahmed N
Journal: BMC Cancer
Date: May 2014
 

 

Granulocyte colony-stimulating factor receptor signalling via Janus kinase 2/signal transducer and activator of transcription 3 in ovarian cancer
Kumar J, Fraser FW, Riley C, Ahmed N, McCulloch DR, Ward AC 
Journal: Br J Cancer
Date: Nov 2013
 

 

Short-term single treatment of chemotherapy results in the enrichment of ovarian cancer stem cell-like cells leading to an increased tumor burden
Abubaker K, Latifi  A, Luwor  R, Nazaretian  S, Zhu  H, Quinn M, Thompson E, Findlay J, Ahmed  N 
Journal: Molecular Cancer
Date: Mar 2013

 

Investigation of human cationic antimicrobial protein-18 (hCAP-18), lactoferrin and CD163 as potential biomarkers for ovarian cancer
Lim R, Lappas M, Riley C, Borregaard N, Moller HJ, Ahmed N, Rice GE 
Journal: J Ovarian Research
Date: Jan 2013
 

 

Isolation and characterization of tumor cells from the ascites of ovarian cancer patients: molecular phenotype of chemoresistant ovarian tumors
Latifi A, Luwor RB, Bilandzic M, Nazaretian S, Stenvers K, Pyman J, Zhu H, Thompson EW, Quinn MA, Findlay JK, Ahmed N 
Journal: PloS One
Date: Oct 2012
 

 

Contribution of fibroblast and mast cell (afferent) and tumor (efferent) IL-6 effects within the tumor microenvironment
Hugo HJ, Lebret S, Thomaskovic-Crook E, Ahmed N, Blick T, Newgreen DF, Thompson EW and Ackland L 
Journal: Cancer Microenvironment 
Date: Apr 2012

 

Cisplatin treatment of primary and metastatic epithelial ovarian carcinomas generates residual cells with mesenchymal stem cell-like profiles 
Latifi A, Abubaker K, Castrechini N, Ward A, Dobill F, Thompson EW, Quinn MA,  Findlay JK and Ahmed N 
Journal: Journal of Cellular Biochemistry 
Date: Oct 2011
 

 

2D-PAGE of Ovarian Cancer: Analysis of soluble and insoluble fractions using narrow pH ranges
Lim R, Lappas M, Ahmed N, Permezel M and Quinn MA, Rice GE
Journal: Biochemical and Biophysical Research Communication
Date: Feb 2011
 

 

Effect of silencing neutrophil gelatinase-associated lipocalin in ovarian cancer cells on epithelio-mesenchymal transition
Lim R, Lappas M, Ahmed N, Borregaard N, Quinn MA and Rice GE 
Journal: Journal of Molecular Biomarkers and Diagnosis
Date: Aug 2011
 

 

Neuronal transcription factor Brn-3a is over expressed in high-grade ovarian carcinomas and tumor cells from ascites of patients with advanced-stage ovarian cancer
Ahmed N, Latifi A, Findlay JK, and Quinn MA
Journal: Journal of Ovarian Research
Date: Jul 2010
 

 

Epidermal growth factor induced ovarian carcinoma cell migration is associated with JAK2/STAT3 signals and changes in the abundance and localization of a6b1 integrin
Colomiere M, Findlay J, Ackland L and Ahmed N 
Journal: Int J Biochemistry Cell Biology
Date: Dec 2008
 

 

Cross talk of signals between EGFR and IL-6R via JAK2/STAT3 mediate epithelial-mesenchymal transition in ovarian carcinomas
Colomiere M, Ward A, Riley C, Trenerry M, Smith DC, Findlay J, Ackland L and Ahmed N 
Journal: British J of Cancer
Date: Dec 2008
 

 

Immunohistochemical perspective of PPARb and one of its putative targets PDK1 in normal ovaries, benign and malignant ovarian tumours
Ahmed N, Riley C and Quinn M 
Journal: British J of Cancer
Date: Mat 2008
 

 

Neutrophil gelatinase-associated lipocalin (NGAL) an early-screening biomarker for ovarian cancer: NGAL is associated with epidermal growth factor-induced epithelio-mesenchymal transition
Lim R, Ahmed N, Borregaard N, Riley C, Wafai R, Thompson EW, Quinn MA, Rice GE
Journal: International Journal of Cancer
Date: Feb 2007
 

 

a2b1 integrin affects metastatic ability of ovarian carcinoma spheroids by supporting disaggregation and proteolysis
Shield K, Riley C, Quinn M, Rice G, Ackland L and Ahmed N 
Journal: J Carcinogenesis
Date: Jun 2007
 

 

Molecular pathways regulating epidermal growth factor-induced epithelio-mesenchymal transition in human ovarian surface epithelium
Ahmed N, Maines-Bandiera S, Quinn MA, Unger WG,  Dedhar S and Auersperg N 
Journal: American J of Physiology: Cell Physiology
Date: 
 

 

Proteomics tracking of serum protein isoforms as screening biomarkers of ovarian cancer
Ahmed N, Oliva K, Barker G, Hoffman P, Reeve S, Smith I, Quinn MA and Rice GE
Journal: Proteomics
Date: Nov 2005
 

 

Role of integrin receptors for fibronectin, collagen and laminin in the regulation of ovarian carcinoma functions in response to a matrix microenvironment
Ahmed N, Riley C, Rice GE and Quinn MA
Journal: Clin Expt Metastasis 
Date: Jun 2005
 

 

Ascites induces modulation of a6 integrin and urokinase plasminogen activator receptor expression and associated functions in ovarian carcinoma
Ahmed N, Riley C, Oliva K, Rice GE and Quinn MA 
Journal: British J of Cancer
Date: Apr 2005
 

 

Enhanced expressionof peroxisome proliferator receptor g expression in ovarian carcinoma
Zhang Q, Ahmed N, Riley C, Oliva K, Quinn MA and Rice GE
Journal: British J of Cancer
Date: Jan 2005
 

 

Proteomics based identification of hatoglobin-1 precursor as a novel circulating biomarker for ovarian cancer
Ahmed N, Barker G, Oliva K, Riley C, Hoffman P, Kemp B, Quinn MA and Rice GE 
Journal: British J of Cancer
Date: Jun 2004
 

 

Cell-free 59 kDa Immunoreactive integrin-linked kinase: a novel marker for ovarian carcinoma
Ahmed N, Oliva K, Rice GE and Quinn MA
Journal: Clinical Cancer Research
Date: Apr 2004
 

 

Expression and localization of avb6 integrin in extraplacental fetal membranes: possible role in human parturition
Ahmed N, Riley C, Oliva K, Barker G, Quinn MA and Rice GE 
Journal: Molecular Human Reproduction
Date: Jan 2004
 

 

Integrin-linked kinase expression increases with ovarian tumour grade and is sustained by peritoneal tumour fluid
Ahmed N, Riley C, Oliva K, Stutt E, Rice GE and Quinn MA 
Journal: J of Pathology
Date: Oct 2003
 

 

An approach to remove albumin for the proteomic analysis of low abundance biomarkers in human serum
Ahmed N, Barker G, Oliva K, Quinn MA and Rice GE 
Journal: Proteomics
Date:  Oct 2003
 

 

Down regulation of urokinase plasminogen activator expression inhibits Erk signaling with concomitant suppression of matrix metalloprotease-9 (MMP-9) due to loss of uPAR-b1 integrin complex in colon cancer
Ahmed N, Oliva K, Wang Y, Quinn MA and Rice GE 
Journal: British J of Cancer
Date: Jul 2003
 

 

Proteomic profiling of proteins associated with urokinase plasminogen activator receptor (uPAR) in colon cancer cells using an antisense approach
Ahmed N, Oliva K, Wang Y, Quinn MA and Rice GE 
Journal: Proteomics
Date: Mar 2003
 

 

avb6 Integrin- A marker for the malignant potential of epithelial ovarian cancer
Ahmed N, Riley C, Rice GE, Quinn MA and Baker MS 
Journal: J Hist. Cytochem
Date: Oct 2002
 

 

Direct integrin avb6-Erk binding: implications for tumour growth
Ahmed N, Niu J, Dorahy DJ, Gu X, Andrews S, Meldrum C, Scott RJ, Baker MS, Macreadie I and Agrez MV
Journal: Oncogene
Date: Feb 2002
 

 

Association between avb6 integrin expression, elevated p42/44 MAPK and plasminogen-dependent matrix degradation in ovarian cancer
Ahmed N, Pansino F, Baker MS, Rice GE and Quinn MA 
Journal: Journal Cellular Biochemistry
Date: Jun 2005
 

 

Overexpression of avb6 integrin in serous epithelial ovarian cancer regulates extracellular matrix degradation via the plasminogen activation cascade
Ahmed N, Pansino F, Riley C, Murthi P, Quinn MA, Rice GE, Agrez MV, Mok S, Baker MS 
Journal: Carcinogenesis
Date: Feb 2002
 

 

Integrin expression in colon cancer cells is regulated by the cytoplasmic domain of the b6 integrin subunit
Niu J, Dorahy DJ, Gu X, Scott RJ, Draganic B, Ahmed N, and Agrez MV 
Journal: Int. J. Cancer
Date: Apr 2002
 

 

The avb6 integrin regulates its own expression with cell crowding: implications for tumor progression
Niu J, Gu X, Ahmed N, and Agrez MV 
Journal: Int. J. Cancer
Date: Apr 2001
 

 

Ceramides that mediate apoptosis reduce glucose uptake and transporter affinity for glucose in human leukaemic cell lines but not in neutrophils
Ahmed N and Berridge MV 
Journal: Pharmacology and Toxicology
Date: Sep 1999
 

 

N -glycosylation of glucose transporter-1 (Glut-1) is associated with increased transporter affinity for glucose in human leukemic cells
Ahmed N and Berridge MV 
Journal: Leukemia Research
Date: 
 

 

Distinct regulation of glucose transport by Interleukin-3 and oncogenes in a murine bone marrow derived cell line
Ahmed N and Berridge MV 
Journal: Biochemical Pharmacology
Date: Sep 1999
 

 

New insights into mammalian sugar transport and its regulation at the plasma membrane
Berridge MV, Tan AS, Ahmed N, Kansara M, Wharton J and Gush J 
Journal: NZ BioScience
Date: 
 

 

IL-3 induces apoptosis: Differential effect of IL-3 on the survival and growth response of parental and oncogene-transfected cells
Ahmed N and Berridge MV 
Journal: Apoptosis
Date: 
 

 

Transforming oncogenes regulate glucose transport by increasing transporter affinity for glucose: Contrasting effects of oncogenes and heat stress in a murine bone marrow-derived cell line
Ahmed N and Berridge MV 
Journal: Life Sciences
Date: 
 

 

Telomerase activity in a specific cell subset coexpressing integrin b1/EGFR but not p75NGFR/bcl2 in normal human epithelial cell
Kunimura C, Kikuchi K, Ahmed N, Shimizu A and Yasumoto S 
Journal: Oncogene
Date: Aug 1998
 

 

Acute regulation of glucose transport after activation of human peripheral blood neutrophils by phorbol myristate acetate, fMLP and granulocyte-macrophage colony-stimulating factor
Tan AS, Ahmed N and Berridge MV 
Journal: Blood
Date: 1998
 

 

Acute regulation of glucose transport in a monocyte-macrophage cell line: Glut-3 activity for glucose is enhanced during the respiratory burst
Ahmed N, Kansara M and Berridge MV 
Journal: Biochem J
Date: Oct 1997
 

 

Regulation of glucose transport by interleukin-3 in growth factor-dependent and oncogene-transformed bone marrow derived cell lines
Ahmed N and Berridge MV 
Journal: Leukemia Research
Date: Jul 1997
 

 

The hemopoietic growth factor, interleukin-3, promotes glucose transport by increasing the specific activity and maintaining the affinity for glucose of plasma membrane glucose transporters in a bone marrow-derived cell line: Possible involvement of phosphorylation in the activation of transporters
McKoy K, Ahmed N and Berridge MV
Journal: J Biol. Chem.
Date: Jul 1997
 

 

Interaction of reactive nitrogen and oxygen intermediates in HL60 and dimethyl sulphoxide-differentiated HL60 cells
Ahmed N and Weidemann MJ 
Journal: Leukemia Research
Date: Mar 1996
 

 

Biochemical effect of three different inhibitors of purine/pyrimidine metabolism on differentiation in HL60 cells
Ahmed N and Weidemann MJ 
Journal: Leukemia Research
Date: Apr 1995
 

 

Purine metabolism in promyelocytic HL60 and dimethyl sulphoxide-differentiated HL60 cells
Ahmed N and Maurice. J. Weidemann 
Journal: Leukemia Research
Date: Jun 1994
 

 

Glycolytic, glutaminolytic and pentose-phosphate pathways in promyelocytic HL60 and DMSO-differentiated HL60 cells
Ahmed N, Williams JF and Weidemann MJ 
Journal: Biochem. & Mol. Biol. Int
Date: Apr 1993
 

 

The Human promyelocytic HL60 cell line: A model of myeloid cell differentiation using dimethylsulphoxide, phorbol ester and butyrate
Ahmed N, Williams JF and Weidemann MJ 
Journal: Biochem. Int
Date: Feb 1991
 

 

Oral Cholera vaccines containing b-subunit-killed whole cells and whole cells only. Cross reacting antigens of the members of family Vibrionaceae and the vaccines
Ahmed (Hussain) N, Ahsan CR, Kay BA, Clemens JD and Sack DA
Journal: Vaccine
Date: Apr 1989
 

 

The impact of low dose carcinogens and environmental disrupters on tissue invasion and metastasis
Ochieng  J, Nangami G, Ogunkua B, Miousse IR,  Kotubash I, Odero-Marah V, McCawley L, Nangia-Makker P, Ahmed N, Luqman Yi, Chen Z, Papagerakis S,Dong C, Zhou BP, Brown D, Colacci A, Hamid RA, Mondello C, Raju J, Ryan E, Woodrick J,Ivana S , Singh N,Vaccari M, Roy R, Forte S, Memeo L ,Salem HK, Amedei A, Al-Temaimi R , Mulla F, Bisson WH and Eltom S 
Journal: Carcinogenesis
Date: Feb 1991
 

 

Assessing the carcinogenic potential of low-dose exposures to chemical mixtures in the environment: the challenge ahead
Goodson WH, Lowe L, Carpenter DO, ……………Ahmed N 
Journal: Carcinogenesis
Date: Jun 2015
 

 

Ovarian cancer stem cells: Molecular concepts and relevance as therapeutic targets
Ahmed N, Abubaker K, Findlay JK
Journal: Carcinogenesis
Date: Jun 2013
 

 

Getting to know ovarian cancer ascites: Opportunities for targeted therapy-based translational research
Ahmed N and Stenvers KL 
Journal: Frontiers in Oncology
Date: Sep 2013
 

 

Cancerous ovarian stem cells: obscure targets for therapy but relevant to chemoresistance
Ahmed N, Abubaker K, Findlay J, Quinn M 
Journal: J Cellular Biochemistry
Date: Jan 2013
 

 

Attributes of Oct4 in stem cell biology: Perspectives on cancer stem cells of the ovary
Samardzija C, Quinn M, Findlay JK, Ahmed N
Journal: J Ovarian Research
Date: Nov 2012
 

 

Epithelial mesenchymal transition and cancer stem cell-like phenotypes facilitate chemoresistance in recurrent ovarian cancer
Ahmed N, Abubaker K, Findlay J and Quinn M
Journal: Current Cancer Drug Target
Date: Apr 2010
 

 

Multicellular spheroids in ovarian cancer metastases: Biology and pathology
Shield K, Ackland L, Ahmed N and Rice G 
Journal: Gynecology Oncology 
Date: Apr 2009
 

 

Epithelial-Mesenchymal interconversions in normal ovarian epithelium and ovarian carcinomas: an exception to the norm
Ahmed N, Thompson E and Quinn M 
Journal: J of Cellular Physiology
Date: Dec 2007
 

 

Translational Proteomics: Developing a predictive capacity
Rice G, Georgiou H, Ahmed N, Shi G and Kruppa G
Journal: Placenta
Date: Nov 2005
 

 

Strategies for revealing lower abundance proteins in two-dimensional protein maps 
Ahmed N and Rice G
Journal: J of Chromatography
Date: Mar 2005